BusinessZIVO Bioscience and Tianjin Norland Biotech Execute Letter of Intent to Produce ZIVO Algae Strain in China for International and Domestic MarketsBy Nasdaq OMXFeb 1, 2018, 12:52 PM UTC
BusinessZIVO Bioscience, Inc. Annual Shareholder Meeting and Conference Call Slated for November 8, 2017 in Detroit, MichiganBy Nasdaq OMXNov 7, 2017, 1:17 PM UTC
BusinessZIVO Bioscience and NutriQuest LLC Conclude Two Poultry Studies With Positive Results, Continue to Move Forward With FDA ComplianceBy Nasdaq OMXSep 19, 2017, 1:42 PM UTC
BusinessZIVO Bioscience, Inc. Kicks Off Final Phase of Bovine Mastitis StudyBy Nasdaq OMXSep 11, 2017, 12:01 PM UTC
BusinessZIVO Bioscience, Inc. Executes Definitive Agreement With NutriQuest, Commences Poultry Field TrialBy Nasdaq OMXApr 26, 2017, 8:36 PM UTC
BusinessZIVO Bioscience, Inc. Debuts New Corporate Website, Shareholder OutreachBy Nasdaq OMXMar 23, 2017, 12:30 AM UTC
BusinessZIVO Bioscience, Inc. Executes Debt Restructuring With Private Equity Firm HEP Investments, LLCBy Nasdaq OMXMar 6, 2017, 10:00 PM UTC
BusinessZIVO Bioscience Expands Algae Cultivation for Compliance and Scaling StudiesBy Nasdaq OMXFeb 2, 2017, 4:41 PM UTC
